Dossier is registered in EU RMS.

License for use of Dossier is related to initial downpayment and commitment to bulk purchase of blisters.

Offer is valid subject to confirmation, country by country. There will be no sales in those countries where this offer would constitute an infringement of third parties intellectual proprietary rights. Farmavita.Net is not owner of offered products/licenses and do not take any liability related to them. However, as the licensing agent we do our the best to facilitate that closed licensing agreements are made on mutual benefit of contracting parties and without infringement of intellectual property of third parties. 

• Intellectual Properties Rights (21/07/2009)
• Famotidine (27/08/2008)
• Diacerein (27/08/2008)

• Ramipril (06/09/2006)
• Triamterene/HCTZ (19/08/2006)
• Triamterene/Epitiazide (19/08/2006)
• Triamterene (19/08/2006)
• Torfenamide (19/08/2006)
• Tolbutamide (19/08/2006)
• Temazepam (19/08/2006)
• Spironolactone (19/08/2006)
• Sotalol (19/08/2006)